Skip to main content
search
El problema de la inercia clínica en DM2
Inyectable Insulinas ENDO

El problema de la inercia clínica en DM2

By enero 13, 2023No Comments

Estimado (a) Dr. (a),

Le invitamos a ver la siguiente cápsula “El problema de la inercia clínica en DM2”.

Por el Profesor Kamlesh Khunti. Universidad de Leicester, Reino Unido.

 

 

Referencias:

  1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998 Sep 12;352(9131):837-53.
  2. Holman RR, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008 Oct 9;359(15):1577-89.
  3. Gerstein HC, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2545-59.
  4. ACCORD Study Group. Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes. Diabetes Care. 2016 May;39(5):701-8.
  5. Patel A, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2560-72.
  6. Zoungas S, et al. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med. 2014 Oct 9;371(15):1392-406.
  7. Duckworth W, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009 Jan 8;360(2):129-39.
  8. Hayward RA, et al. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015 Jun 4;372(23):2197-206.
  9. Turnbull F, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia. 2009 Nov;52(11):2288-98.
  10. Fang M, et al. Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018. N Engl J Med. 2021 Jun 10;384(23):2219-2228.
  11. Khunti K, Davies MJ. Clinical inertia-Time to reappraise the terminology? Prim Care Diabetes. 2017 Apr;11(2):105-106.
  12. Khunti K, et al. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care. 2013 Nov;36(11):3411-7.
  13. Khunti K, et al. Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review. Diab Obes Metab 2018 Feb;20(2):427-437.
  14. Peyrot M, et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care. 2005 Nov;28(11):2673-9.
  15. Elgrably et al. Initiation of insulin treatment after 70 years of age: patient status 2 years later. Diabet Med. 1991 Oct;8(8):773-7.
  16. Wallace TM, Matthews DR. Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude. QJM. 2000 Jun;93(6):369-74.
  17. Kunt T, Snoek FJ. Barriers to insulin initiation and intensification and how to overcome them. Int J Clin Pract. 2009 Oct;(164):6-10.
  18. Powell RE, et al. Strategies for overcoming therapeutic inertia in type 2 diabetes: A systematic review and meta-analysis. Diab Obes Metabol. 2021 Sep;23(9):2137-2154.
  19. Prato S, et al. Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. Int J Clin Pract. 2005 Nov;59(11):1345-55. 

 

 

Material desarrollado con fines de educación médica continua.

Material exclusivo para profesionales de la salud.

La información aquí presentada es opinión del ponente.

Código interno de aprobación: MX22NNM00121.

Leave a Reply

Close Menu